Author:
Ikram Aqsa,Rauff Bisma,Alzahrani Badr,Awan Faryal Mehwish,Obaid Ayesha,Naz Anam,Kakar Salik Javed,Janjua Hussnain Ahmed
Abstract
AbstractMany PTMs dysregulation is known to be the major cause of many cancers including HCV induced HCC. PTMs of hepatitis C virus (HCV) regions NS3/4A, NS5A and NS5B are crucial for proper protein functions and replication that directly affect the generation of infectious virus particles and completion of its life cycle. In this study, we have performed comprehensive analysis of PTMs within HCV non-structural proteins (NS3/4A, NS5A and NS5B) through bioinformatics analysis to examine post-translational crosstalk between phosphorylation, palmitoylation, methylation, acetylation and ubiquitination sites in selected viral proteins. Our analysis has revealed many highly putative PTMs sites that are also conserved among major genotypes conferring the importance of these sites. We have also analysed viral 3D structures in their modified and unmodified forms to address extent and signatures of structural changes upon PTM. This study provides evidence that PTMs induce significant conformational changes and make viral proteins more stable. To find the potential role of PTMs in HCV induced HCC, docking analysis between selected viral proteins and p38-MAPK has been performed which also confirms their strong association with HCV induced HCC. The major findings proposed that PTMs at specific sites of HCV viral proteins could dysregulate specific pathways that cause the development of HCC.
Publisher
Springer Science and Business Media LLC
Reference66 articles.
1. Blanchard, E. et al. Hepatitis C virus-like particle morphogenesis. J. Virol. 76(8), 4073–4079 (2002).
2. Maasoumy, B. & Wedemeyer, H. Natural history of acute and chronic hepatitis C. Best Pract. Res. Clin. Gastroenterol. 26(4), 401–412 (2012).
3. Lynch, S. M. & Wu, G. Y. Hepatitis C virus: A review of treatment guidelines, cost-effectiveness, and access to therapy. J. Clin. Transl. Hepatol. 4(4), 310 (2016).
4. Geddawy, A. et al. Direct acting anti-hepatitis C virus drugs: Clinical pharmacology and future direction. J. Transl. Intern. Med. 5(1), 8–17 (2017).
5. Ribet, D. & Cossart, P. Pathogen-mediated posttranslational modifications: A re-emerging field. Cell 143(5), 694–702 (2010).
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献